Literature DB >> 19263332

Universal tuberculosis screening in pregnancy.

Nadav Schwartz1, Sarah A Wagner, Sean M Keeler, Julian Mierlak, David E Seubert, Aaron B Caughey.   

Abstract

We reviewed our practice of universal tuberculosis (TB) screening in an at-risk pregnant population with regards to utility and patient compliance. The Gouverneur Healthcare Services prenatal database was analyzed for compliance with TB screening. Age, ethnicity, country of origin, and education level were also analyzed. Of 4049 patients, 95.0% were compliant with their purified protein derivative (PPD) testing. Universal screening identified 1935 (50.4%) PPD+ patients, with chest X-rays (CXR) available for 95.1%. Only one patient had a CXR consistent with active TB, although sputum testing was negative for acid-fast bacilli. Asian women were more likely to be PPD-compliant (adjusted odds ratio [aOR]: 4.94, 95% confidence interval [CI]: 2.34 to 10.45). Similarly, PPD+ Asian women were more likely to be compliant with CXR (aOR: 12.67, 95% CI: 3.44 to 46.7). U.S.-born women were significantly less likely to be compliant with PPD (aOR: 0.44, 95% CI: 0.30 to 0.64) or with CXR (aOR: 0.22, 95% CI: 0.08 to 0.61). Universal prenatal TB screening is associated with excellent compliance rates and is an effective way to identify a high prevalence of latent TB, but not active disease.

Entities:  

Mesh:

Year:  2009        PMID: 19263332     DOI: 10.1055/s-0029-1214244

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  7 in total

1.  Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.

Authors:  Ruth N Moro; Nigel A Scott; Andrew Vernon; Naomi K Tepper; Stefan V Goldberg; Kevin Schwartzman; Chi-Chiu Leung; Neil W Schluger; Robert W Belknap; Richard E Chaisson; Masahiro Narita; Elizabeth S Machado; Marta Lopez; Jorge Sanchez; Margarita E Villarino; Timothy R Sterling
Journal:  Ann Am Thorac Soc       Date:  2018-05

2.  Comparing an Interferon Gamma Release Assay with the Tuberculin Skin Test During Pregnancy: Implications for Tuberculosis Screening During Prenatal Care.

Authors:  Rose Molina; Kartik Venkatesh; Julianna Schantz-Dunn; Audra Meadows; Nawal Nour; Khady Diouf
Journal:  Matern Child Health J       Date:  2016-06

Review 3.  Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps.

Authors:  Jyoti S Mathad; Amita Gupta
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

4.  Risk of Adverse Infant Outcomes Associated with Maternal Tuberculosis in a Low Burden Setting: A Population-Based Retrospective Cohort Study.

Authors:  Sylvia M LaCourse; Sharon A Greene; Elizabeth E Dawson-Hahn; Stephen E Hawes
Journal:  Infect Dis Obstet Gynecol       Date:  2016-02-16

5.  Low Prevalence of Active Tuberculosis among High-Risk Pregnant and Postpartum Women in Sweden: A Retrospective Epidemiological Cohort Study Using and Evaluating TST as Screening Method.

Authors:  Maria Bullarbo; Martina Barnisin; Nina Vukas Radulovic; Åsa Mellgren
Journal:  Infect Dis Obstet Gynecol       Date:  2018-07-18

6.  Prevalence, acceptability, and cost of routine screening for pulmonary tuberculosis among pregnant women in Cotonou, Benin.

Authors:  Mênonli Adjobimey; Serge Ade; Prudence Wachinou; Marius Esse; Lydia Yaha; Wilfried Bekou; Jonathon R Campbell; Narcisse Toundoh; Omer Adjibode; Geoffroy Attikpa; Gildas Agodokpessi; Dissou Affolabi; Corinne S Merle
Journal:  PLoS One       Date:  2022-02-22       Impact factor: 3.240

Review 7.  Latent Tuberculosis in Pregnancy: A Systematic Review.

Authors:  Isabelle Malhamé; Maxime Cormier; Jordan Sugarman; Kevin Schwartzman
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.